Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium (186Re) Obisbemeda for the treatment of patients ...
Operator Good day and welcome to the J&J Snack Foods fiscal 2024 fourth quarter conference call. At this time, all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback